Quantinno Capital Management LP increased its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 40.3% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 28,968 shares of the financial services provider's stock after buying an additional 8,320 shares during the period. Quantinno Capital Management LP's holdings in CME Group were worth $6,727,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Vanguard Group Inc. lifted its holdings in shares of CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after purchasing an additional 326,623 shares in the last quarter. Geode Capital Management LLC lifted its position in CME Group by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock valued at $1,946,717,000 after purchasing an additional 104,697 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. Norges Bank bought a new stake in CME Group in the 4th quarter worth approximately $1,107,389,000. Finally, FIL Ltd raised its stake in CME Group by 1.5% during the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after buying an additional 61,908 shares during the last quarter. Institutional investors own 87.75% of the company's stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on CME. Piper Sandler lifted their price target on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 8th. Morgan Stanley raised their price objective on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Erste Group Bank upgraded CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Raymond James upgraded CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price for the company in a research report on Monday, March 10th. Finally, Bank of America boosted their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, CME Group has an average rating of "Hold" and a consensus price target of $256.80.
View Our Latest Report on CME
CME Group Trading Down 0.0%
Shares of CME stock traded down $0.07 on Tuesday, reaching $277.87. 1,389,173 shares of the company's stock were exchanged, compared to its average volume of 2,179,996. The company's fifty day simple moving average is $266.29 and its 200 day simple moving average is $247.71. The stock has a market capitalization of $100.13 billion, a PE ratio of 28.74, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $286.48.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a return on equity of 13.62% and a net margin of 57.52%. CME Group's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.50 earnings per share. As a group, analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Monday, June 9th will be issued a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.80%. CME Group's payout ratio is currently 50.30%.
Insider Buying and Selling
In other news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the transaction, the director now owns 21,873 shares of the company's stock, valued at $5,686,980. The trade was a 31.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the business's stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. This represents a 12.84% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,494 shares of company stock valued at $7,281,618 over the last three months. 0.30% of the stock is owned by company insiders.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report